|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
53,520,000 |
Market
Cap: |
36.18(M) |
Last
Volume: |
446,593 |
Avg
Vol: |
445,374 |
52
Week Range: |
$0.676 - $0.676 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
375,965 |
670,478 |
670,478 |
670,478 |
Total Buy Value |
$343,753 |
$610,569 |
$610,569 |
$610,569 |
Total People Bought |
1 |
1 |
1 |
1 |
Total Buy Transactions |
25 |
37 |
37 |
37 |
Total Shares Sold |
0 |
30,110 |
30,110 |
30,110 |
Total Sell Value |
$0 |
$26,460 |
$26,460 |
$26,460 |
Total People Sold |
0 |
2 |
2 |
2 |
Total Sell Transactions |
0 |
5 |
5 |
5 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Ramos Anthony Alan |
Chief Accounting Officer |
|
2014-01-23 |
4 |
D |
$1.59 |
$130 |
D/D |
(82) |
101,929 |
|
- |
|
Ramos Anthony Alan |
Chief Accounting Officer |
|
2014-01-21 |
4 |
D |
$1.66 |
$272 |
D/D |
(164) |
102,011 |
|
- |
|
Ramos Anthony Alan |
Chief Accounting Officer |
|
2014-01-19 |
4 |
D |
$1.66 |
$272 |
D/D |
(164) |
102,175 |
|
- |
|
Samant Vijay B |
President & CEO |
|
2014-01-13 |
4 |
D |
$1.34 |
$1,962 |
D/D |
(1,464) |
950,726 |
|
- |
|
Smith Lawrence Russell |
VP, Vaccine Research |
|
2014-01-13 |
4 |
D |
$1.34 |
$409 |
D/D |
(305) |
195,125 |
|
- |
|
Bilinsky Igor |
Senior VP, Corporate Devt |
|
2014-01-13 |
4 |
D |
$1.34 |
$409 |
D/D |
(305) |
143,968 |
|
- |
|
Samant Vijay B |
President & CEO |
|
2014-01-11 |
4 |
D |
$1.42 |
$14,230 |
D/D |
(10,021) |
952,190 |
|
- |
|
Smith Lawrence Russell |
VP, Vaccine Research |
|
2014-01-11 |
4 |
D |
$1.42 |
$2,829 |
D/D |
(1,992) |
195,430 |
|
- |
|
Bilinsky Igor |
Senior VP, Corporate Devt |
|
2014-01-11 |
4 |
D |
$1.42 |
$2,015 |
D/D |
(1,419) |
144,273 |
|
- |
|
Samant Vijay B |
President & CEO |
|
2014-01-10 |
4/A |
A |
$0.01 |
$3,300 |
D/D |
330,000 |
950,726 |
|
- |
|
Bilinsky Igor |
Senior VP, Corporate Devt |
|
2014-01-10 |
4/A |
A |
$0.01 |
$900 |
D/D |
90,000 |
143,968 |
|
- |
|
Ramos Anthony Alan |
Chief Accounting Officer |
|
2014-01-10 |
4/A |
A |
$0.01 |
$700 |
D/D |
70,000 |
102,339 |
|
- |
|
Smith Lawrence Russell |
VP, Vaccine Research |
|
2014-01-10 |
4/A |
A |
$0.01 |
$900 |
D/D |
90,000 |
195,125 |
|
- |
|
Samant Vijay B |
President & CEO |
|
2014-01-10 |
4 |
B |
$1.42 |
$468,600 |
D/D |
330,000 |
962,211 |
2.81 |
- |
|
Smith Lawrence Russell |
VP, Vaccine Research |
|
2014-01-10 |
4 |
B |
$1.42 |
$127,800 |
D/D |
90,000 |
197,422 |
2.74 |
- |
|
Ramos Anthony Alan |
Chief Accounting Officer |
|
2014-01-10 |
4 |
B |
$1.42 |
$99,400 |
D/D |
70,000 |
102,339 |
2.74 |
- |
|
Bilinsky Igor |
Senior VP, Corporate Devt |
|
2014-01-10 |
4 |
B |
$1.42 |
$127,800 |
D/D |
90,000 |
145,692 |
2.74 |
- |
|
Bilinsky Igor |
Senior VP, Corporate Devt |
|
2014-01-07 |
4 |
D |
$1.31 |
$71 |
D/D |
(54) |
55,692 |
|
- |
|
Smith Lawrence Russell |
VP, Vaccine Research |
|
2014-01-07 |
4 |
D |
$1.31 |
$858 |
D/D |
(655) |
107,422 |
|
- |
|
Bilinsky Igor |
Senior VP, Corporate DevtOffic |
|
2013-12-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
55,746 |
|
- |
|
Smith Lawrence Russell |
VP, Vaccine ResearchOfficer |
|
2013-12-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
108,077 |
|
- |
|
Ramos Anthony Alan |
Chief Accounting Officer |
|
2013-11-12 |
4 |
S |
$1.11 |
$8,789 |
D/D |
(7,918) |
32,339 |
|
- |
|
Ramos Anthony Alan |
Chief Accounting Officer |
|
2013-10-23 |
4 |
D |
$1.49 |
$122 |
D/D |
(82) |
40,257 |
|
- |
|
Ramos Anthony Alan |
Chief Accounting Officer |
|
2013-10-21 |
4 |
D |
$1.36 |
$222 |
D/D |
(163) |
40,339 |
|
- |
|
Ramos Anthony Alan |
Chief Accounting Officer |
|
2013-10-19 |
4 |
D |
$1.34 |
$218 |
D/D |
(163) |
40,502 |
|
- |
|
583 Records found
|
|
Page 12 of 24 |
|
|